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FAKNull mutations in the pea3 allele compromise the capacity of mammary tumors to metastasize in MMTV-Neu/
ErbB2/HER2 transgenic mice, indicating a motility defect in PEA3-null cells. Cellular and biochemical analyses
of established PEA3-null ﬁbroblasts show impaired motility and aberrant localization of adhesion proteins in
spreading cells. Our results show that PEA3−/− cells express normal levels of key adhesion components, but
that spreading PEA3-null cells fail to activate c-src and to downregulate phospho-FAK(Y397), suggesting that
focal adhesion signaling is impaired. Supporting this, biochemical analysis revealed that adhesion complex-
associated proteins such as p130Cas failed to undergo tyrosine phosphorylation and dissociated from the ad-
hesion complex with delayed kinetics. Overall our data show that the motility defects observed in PEA3-null
cells are due to altered adhesion signaling.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
PEA3/E1AF/ETV4 is the founding member of a subfamily of ETS
transcription factors implicated in the gene regulation of membrane
receptors, growth factors and extracellular matrix metalloproteinases
[1,2]. PEA3 proteins have been shown to be overexpressed in the vast
majority of human breast and ovarian tumors and in nearly all of
the human epidermal growth factor receptor 2 (HER2/Neu/ErbB2)-
positive subclass of breast tumors [3–6]. Interestingly, null mutations
in the pea3 allele compromise the capacity of mammary tumors to
metastasize in MMTV-Neu/HER2/ErbB2 transgenic models of breast
cancer [7–9]. In contrast, overexpression of PEA3 in MCF7 human
breast tumor cells increases their metastatic potential [10], whereas
PEA3 antisense RNA reduces the invasiveness of human tumor cells
[11]. These results strongly suggest a role for PEA3 in the regulation
of target genes important for the control of cell motility.
Cell adhesion and migration involves the dynamic assembly and
disassembly of adhesion components at the leading edge of migrating
cells. Stimulation of cell adhesion and migration induces the formation
of an integrin-FAK-src complex that is required for the recruitment and
activation of a number of adaptor molecules leading to focal adhesionCenter, 501 Smyth Rd, Box 926,
79963; fax: +1 613 247 3524.
y of Ottawa, 43 Bruyère Street,
rights reserved.turnover and migration [12–14]. Indeed, FAK-null cells assemble large
and stable adhesion complexes leading to migratory deﬁcits [15]. Simi-
larly, a FAK mutant at tyrosine 397, deﬁcient for c-src binding, fails to
induce focal adhesion disassembly in FAK-deﬁcient ﬁbroblasts [16,17].
Supporting this, src-family kinase-deﬁcient cells or expression of kinase
inactive v-src in ﬁbroblasts display larger focal adhesions that fail to dis-
assemble [18,19].
The reduced capacity of PEA3-null breast tumors to metastasize sug-
gests that PEA3 regulates a subset of genes important formotility and in-
vasion. To gain insight into the migratory defect of PEA3(−/−) cells, we
have characterized the subcellular distribution of adhesion markers and
the association of adapter proteins with the FAK-src complex in
PEA3-nullﬁbroblasts. Our results show that PEA3(−/−) cells exhibitmi-
gration deﬁciencies in Boyden chamber assays. Although PEA3−/− cells
display normal distribution of focal adhesions, re-plating on ﬁbronectin
(FN) shows reduced c-src activation and delayed focal complex disas-
sembly. Our results suggest that a subset of PEA3 target genes encodes
proteins implicated in c-src regulation and focal adhesion signaling.
2. Materials and methods
2.1. Cell lines and cell culture
The pea3-null mouse embryonic ﬁbroblast cell lines, PEA3(−/−)1,
2 and 3, as well as the PEA3(−/−) cells stably expressing PEA3 cDNA
and the wild-type cells (WT) were derived from PEA3(−/−) E13.5
embryos [7] and established following the 3T3 protocol. All cell lines
Fig. 1. PEA3(−/−) cells exhibit migration deﬁciencies. (A and B) Conﬂuent monolayers
growing on FN-coated coverslips were scratched with a pipette tip allowed to close the
wound for 6 h (C and D). The cells were then ﬁxed and stained with TRITC-phalloidin.
Wildtype cells migrated towards the wound more efﬁciently than PEA3(−/−) cells.
PEA3(−/−) cells do not form any ﬁllipodia or microspike structures. Representative
wound closure assays are shown. The cells were photographed at ×200. (E-H) Quanti-
tation of migration. WT, PEA3(−/−)-1, -2, -3 and PEA3(−/−)+PEA3 cells were incu-
bated in Boyden chambers coated with BSA or FN for 4 h. Membranes were then peeled
off, ﬁxed and stained with DAPI to visualize the migrated cells (A, B and C). (H) Cells
from 4 random ﬁelds were enumerated and are shown as the average from triplicate
wells. Similar results were obtained in three independent experiments.
2238 Z.Y. Chaar et al. / Biochimica et Biophysica Acta 1823 (2012) 2237–2242were maintained at 37 °C in a humidiﬁed atmosphere containing
5% CO2 in Dulbecco's modiﬁed Eagle's medium (DME medium,
Bio-Whitaker) supplemented with 10% fetal bovine serum (FBS),
2 mM L-glutamine, 50 μg/ml penicillin, and 50 μg/ml streptomycin.
For replating assays, subconﬂuent cultures were serum-starved in
0.25% FBS-DME medium for 24 h and harvested by trypsin-EDTA
treatment as described previously [15]. The trypsin was inactivated
using soybean trypsin inhibitor (0.5 mg/ml) (Sigma) and the cells
were collected by centrifugation and resuspended in 0.1% bovine
serum albumin-DME (BSA-DME) (w/v) medium. After 1 h at 37 °C in
suspension, the cells were plated onto FN or Poly-L-Lysine pre-coated
coverslips. The coverslips were pre-coated with FN (10 μg/ml, Sigma)
or Poly-L-Lysine (10 μg/ml, Sigma) in PBS overnight at 4 °C, rinsed
with PBS, and warmed to 37 °C for 1 h prior to replating.
For wound healing assays, exponentially growing cells were plated
onto FN-coated coverslips in complete growthmedium and incubated
overnight at 37 °C. The next day, the monolayer of cells was washed
twice with PBS and once with 0.1% BSA-DME medium. The wound
healing assay was initiated by manually scratching the monolayer
of cells with a pipette tip and allowing migration in 0.1% BSA-DME
medium at 37 °C for 6 h. Migration was quantitated using Millicell
Boyden chambers (Millipore) as described previously [20]. The lower
side of the polycarbonate membranes were pre-coated with BSA (1%
(w/v)) or FN (10 μg/ml) overnight at 4 °C, rinsedwith PBS, andwarmed
to 37 °C for 1 h prior to the initiation of migration. Serum-starved cells
collected and resuspended in 0.1% BSA-DMEmediumwere added to the
upper chamber to initiate cell migration. Following migration, 4 h at
37 °C, both chambers were rinsed with PBS and the lower side of the
membrane was ﬁxed in 4% paraformaldehyde (PFA) and stained with
DAPI. The remaining cells in the upper chamber were removed using
a cotton tip applicator. The number of migrated cells was determined
by counting the DAPI stained cells (cells/ﬁeld using a ×20 objective)
on the underside of the membrane. Cells were enumerated from 5 ran-
dom ﬁelds and averaged.
2.2. Immunoﬂuorescence
Coverslips were ﬁxed in 4% PFA for 10 min at room temperature,
washed in PBS, and blocked with 1% BSA or 200 μg/ml ChromaPure
Goat IgG (Jackson Immunoresearch Laboratories). Focal adhesions
were visualized with a FAK polyclonal (Santa Cruz), a paxillin monoclo-
nal (BD Biosciences) and a mouse anti-vinculin monoclonal antibody
(clone VIN11–5, Sigma) in conjunction with ﬂuorescein isothiocyanate
(FITC)-labeled secondary antibodies. TRITC-conjugated phalloidin was
used to detect actin stress ﬁbers. Samples were visualized on a Zeiss
Axioskop100 epiﬂuorescence microscope equipped with appropriate
ﬁlters and photographed with a digital camera (Sony Corporation
HBO50) using the Northern Eclipse software package.
2.3. Immunoprecipitations and western blots
Cells were rinsed in PBS and protein extracts were made in
modiﬁed RIPA buffer containing 50 mM Tris–HCl (pH 7.4), 150 mM
NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 0.5% (w/v) sodium
deoxycholate, 0.1% (w/v) SDS, 1% (v/v) Nonidet P-40, phosphatase
inhibitors (10 mM NaF, 10 mM β-glycerophophate and 250 μM Na
ortho-vanadate) and protease inhibitors (Sigma inhibitor cocktails).
For western analysis, β1 integrin, PTEN, RhoA, Rac1 and Cdc42 anti-
bodies were from SantaCruz. Anti-vinculin and anti-c-src were ob-
tained from Sigma and anti-paxillin antibodies were purchased from
BD Biosciences. For immunoprecipitations, 400 μg of total cell lysate
was immunoprecipitated using 2 μg of anti-FAK rabbit polyclonal an-
tibody (clone 556368, BD Pharmingen) or anti-paxillin mouse mono-
clonal antibody (clone 610051, BD Biosciences) and 20 μl of protein
A-Sepharose (Amersham Biosciences) for 4 h at 4 °C. Immunoprecip-
itates were washed three times with NETN (50 mM Tris–HCl (pH7.5), 150 mM NaCl, 1 mM EDTA, and 0.1% (v/v) Nonidet P-40) and
eluted with 4× SDS sample buffer (containing 200 mM Tris–HCl
pH6.8; 400 mM DTT; 8% (w/v) SDS; 0.4% (w/v) bromophenol blue
and 40% (v/v) glycerol). Samples were fractionated on 8% SDS-PAGE
and transferred to polyvinylidene diﬂuoride membranes (PVDF).
Membranes were then probed with anti-p130CAS monoclonal anti-
body (P27820, Transduction Laboratories), anti-phospho-p130Cas an-
tibody (Tyr249; 4014S, Cell Signaling) or anti-c-src (Sigma). FAK and
c-src activation was determined by western blotting of whole cell
lysates with rabbit polyclonal anti-FAK phosphospeciﬁc antibodies
for phospho-tyrosine residues 397 (pY397) and anti-c-src phospho-
tyrosine 416 speciﬁc antibody (c-src pY416; Upstate Biotechnology),
respectively. To evaluate the efﬁciency of the immunoprecipitation,
PVDF membranes were stripped using Re-Blot Plus (Chemicon Inter-
national) and re-probed with anti-FAK or anti-paxillin accordingly.
Reactive proteins were detected by enhanced chemiluminescence
(PerkinElmer Life Sciences) using a goat anti-rabbit or anti-mouse
horseradish peroxidase-labeled secondary antibody and visualized
using autoradiography.
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3.1. Impaired motility in PEA3-null ﬁbroblasts
Previous studies have shown that PEA3 is required for the invasive
potential of breast tumors in vivo and in vitro [7–11]. To investigate
whether the reduced invasion potential of PEA3-null tumors was
due in part to a motility defect, three independent PEA3(−/−) ﬁbro-
blast cell lines and a PEA3 reconstituted line were analyzed. All MEF
cell lines have been previously characterized for PEA3 deletion and
expression [21]. The cultures were initially subjected to wound
healing and Boyden chamber haptotactic assays. Following scratch
wounding of the conﬂuent monolayers (Fig. 1A), wildtype (WT) and
PEA3-reconstituted cells nearly closed the wound within 6 h whereas
PEA3-null cells displayed a 40–50% closure. Interestingly, PEA3(−/−)
cells did not seem to form ﬁlopodial structures or extensions into the
wound as did wildtype cells (Fig. 1C and D). To quantitate the ob-
served migratory defect, we performed FN haptotactic assays. All
three PEA3(−/−) cell lines displayed a relative 4-fold decrease in mi-
gration on ﬁbronectin when compared to WT or PEA3-reconstituted
cells (Fig. 1E-H). No differences were observed in random migration
on BSA. Together, these results suggest that PEA3 target gene prod-
ucts regulate important aspects of cell migration.Fig. 2. PEA3(−/−) cells display reduced numbers of focal adhesion complexes. WT and PEA3(
FAK (C and D), paxillin (E and F) or vinculin (G and H). PEA3-null cells display a reduced densit
displayed by the focal adhesion marker staining (panels C–H). Similarly, no differences were o
guishable from WT cells (not shown). The cells were photographed at 630×. (I) Focal adhesio
both wildtype and PEA3-null cells (pb0.01).To gain further insights into the role of PEA3 in cell adhesion and
migration, we have investigated the distribution of adhesion compo-
nents in cells grown on FN. All cultures were immunostained for actin
(phalloidin), FAK, paxillin vinculin, p130Cas and c-src. No differences
were observed in the localization of the focal adhesion components or
signaling molecules (Fig. 2 and Supplemental Fig. 1). Interestingly, a
relative decrease in the density of actin stress ﬁbers was observed in
PEA3−/− cells, suggesting a defect in actin dynamics (Fig. 2 A–B).
Supporting the actin phenotype, wildtype cells displayed more focal
adhesion as assessed by immunostaining for FAK, paxillin and vinculin
(Fig. 2C–H). Interestingly, little differenceswere observed for p130Cas
and c-src localization (Supplemental Fig. 1). Although the overall
number of adhesionswas reduced in PEA3-null cells, their distribution
was not affected. These results suggest that the observed motility de-
fect is likely due to decreased focal adhesion signaling rather than
mislocalization of adhesion components. The reduced number of adhe-
sions may also account for the actin phenotype in PEA3-deﬁcient cells.
3.2. Failure to activate c-src leads to impaired focal adhesion disassembly
in PEA3(−/−) cells
To further investigate the migration defect in PEA3(−/−) cells,
we ﬁrst examined the expression level of key adhesion complex−/−) cells were grown onto FNmatrix, ﬁxed and stained for actin stress ﬁbers (A and B),
y of stress ﬁbers, focal adhesions but a normal distribution of focal adhesion complexes, as
bserved for c-src and p130Cas (not shown). PEA3-reconstituted cell lines were indistin-
ns were enumerated as per FAK staining. Adhesions were counted for at least 20 cells for
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veyed for the expression of β1- and β3-integrin, vinculin, paxillin,
PTEN, c-src, RhoA, Rac1, cdc42 and talin proteins (Fig. 3). Western
blot analysis showed no major differences in the steady state levels
of these different proteins. Furthermore, the levels of active Rac1,
Cdc42 or Y31-phosphorylated paxillin were not altered (data not
shown). Blotting for PEA3, conﬁrmed the absence of PEA expression
in the knock-out ﬁbroblasts. Similar results were observed in a third
PEA3-null line and a PEA3-reconstituted cell line (not shown). Com-
bined with the observed reduction in focal adhesions, these results
suggest that PEA3-null cells have an impaired ability to assemble
focal adhesions rather than reduce levels in focal adhesion component
expression. Because all 3 lines behaved similarly inmotility assays and
were indistinguishable in their adhesion marker expression proﬁle,
PEA3−/− cell line 1 was used in all subsequent experiments.
FN stimulation of ﬁbroblasts has been shown to trigger the activa-
tion of FAK, the recruitment and activation of c-src and the formation
of adhesion signaling complexes mediating actin rearrangements
[22,23]. To test for potential adhesion signaling defects, FN-stimulated
cells were analyzed for FAK activation. Total cell lysates from replated
cells were immunoblotted for FAK phospho-Tyr397 (pY397), an auto-
phosphorylation event indicative of FAK activation and focal adhesion
turnover [14,17,24]. Western blot analysis (Fig. 4A) showed that FAKFig. 3. Expression of focal adhesion components in PEA3(−/−) cells. Equal amounts of
WT, PEA3(−/−)-1, and−2 lysates were resolved by SDS-PAGE, transferred onto PVDF
membranes and immunoblotted for the indicated proteins. No signiﬁcant changes in
the protein expression levels of β1 and β3 integrin, vinculin, paxillin, PTEN, c-src and
the Rho GTPases RhoA, Rac1, as well as talin were observed. Similarly, no differences
were observed in PEA3-reconstituted cells and in a third PEA3-null isolates (not
shown). PEA3 was not expressed in the PEA3−/− lines.
Fig. 4. Abnormal FAK and c-src regulation in PEA3(−/−) cells. (A) Cell lysates from
time course replating assays on FN were surveyed for FAK phospho-Tyr397 (FAK
pY397) and total FAK proteins. FAK pY397 is detected across the time course in
PEA3(−/−) cells as well as in suspension (S). (B) Similarly, cell lysates were
immunoblotted for c-src phospho-Tyr416 (c-src pY416), stripped and re-probed for
total c-src. The two Tyr-416-positive species likely represent c-src and a cross reactive
src-family kinase, possibly c-fyn (arrowheads). Reduced and delayed activation of c-src
(pY416) was observed in PEA3(−/−) cells.pY397 is transiently detected following replating on FN in WT cells
(and in PEA3-reconstituted cells; not shown) as previously reported
[23]. In contrast to WT cells, high levels of FAK pY397 were detected
in all PEA3(−/−) cell lines throughout the replating time course,
suggesting impaired turnover. In addition, high levels of FAK pY397
were also detectable in suspension cells, suggesting that PEA3-null
cells fail to downregulate FAK signaling in suspension (Fig. 4A). Similar-
ly, analysis of pFAK-Y925 levels shows that PEA3-null cells fail to
re-induce tyrosine 925 phosphorylation 60 min following replating,
supporting a turnover defect (Supplemental Fig. 2). We next inves-
tigated c-src activation following FN stimulation. Cell lysates were
immunoblotted for c-src phosphorylation at tyrosine residue 416
(Y416), a phosphorylation event required for c-src maximal activation
[25]. Whereas it was readily detectable in WT and PEA3-reconstituted
cells, c-src pY416 levels were markedly reduced and appeared with de-
layed kinetics (20–30 min) in PEA3(−/−) cells (Fig. 4B). No differences
were observed in the phosphorylation status of c-src Y527 (not shown).
Together these results suggest that PEA3(−/−) cells have impaired ad-
hesion signaling and turnover upon FN stimulation, resulting inmotility
defects.
3.3. p130Cas tyrosine phosphorylation is impaired in the PEA3(−/−)
cells
The scaffolding proteins p130Cas and paxillin have been shown to
bind FAK, resulting in a FAK-src-mediated tyrosine phosphorylation
[26–32]. As for FAK and c-src, paxillin is an important regulator of
cell migration [33] and is necessary for efﬁcient adhesion signaling
[14,17,34]. Similarly, c-src-mediated phosphorylation of p130Cas
has been shown to play an important role in the regulation of cell
Fig. 6. Delayed FAK/c-src/p130Cas complex disassembly in PEA3(−/−) cells. Time
course FN stimulation was performed and FAK was immunoprecipitated fromwildtype
(A), PEA3(−/−) (B) or PEA3(−/)-reconstituted cells. Immunoprecipitates were then
immunoblotted for p130Cas and c-src. p130Cas remained associated with FAK for lon-
ger time periods during the replating assay. No differences in the levels of c-src associ-
ationwith FAKwere observed. C= exponentially growing cells, PL= poly-L-lysine, S=
suspension.
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observed in PEA3-null cells affects adhesion complex formation and
signaling, we examined the association of paxillin and p130Cas with
the adhesion complex following FN stimulation. First, paxillin immu-
noprecipitates from stimulated cells were analyzed for p130Cas and
c-src. Although no differences were observed in c-src association
with paxillin containing complexes (Fig. 5A–C), PEA3-deﬁcient cells
weakly induced p130Cas tyrosine phosphorylation [29,35] upon FN
stimulation (pp130Cas; Y249, Fig. 5B). Interestingly, we observed
that more p130Cas could be co-immunoprecipitated with paxillin
when PEA3−/−cells were replated onto poly-L-lysine (PL) matrix
compared to WT and PEA3-reconstituted cells (Fig. 5B). We next
immunoprecipitated FAK protein from FN stimulated lysates and
immunoblotted for p130Cas. As for paxillin immunoprecipitates,
western blot analysis showed that p130Cas remained associated
with FAK for longer periods on FN but that c-src was unaffected
(Fig. 6A–C; compare 20 and 30 min lanes). These results further sup-
port the notion that PEA3(−/−) cells exhibit focal adhesion signaling
defects due in part to partial c-src activation. Overall, our data suggest
that PEA3 target gene products may regulate c-src activity or focal ad-
hesion assembly, thereby controlling signaling and migration.
4. Discussion
Previous studies have shown that PEA3-null tumors display poor
metastatic potential, suggesting the existence of invasion or motilityFig. 5. p130Cas tyrosine phosphorylation is altered in PEA3(−/−) cells. (A) Time
course FN stimulation of wildtype cells (A), PEA3(−/−) (B) or PEA3-reconstituted
(C) was performed and paxillin immunoprecipitates were immunoblotted for p130Cas,
phosphor-tyrosine p130Cas (Y249; pp130Cas), c- src and paxillin proteins. p130Cas is
detected across the time course of the replating assay in the PEA3(−/−) cells, even
upon replating onto poly-L-lysine (PL) matrix. However, p130Cas remains associated
with the adhesion complex for longer periods (20 and 30 min lanes). In addition, its
tyrosine 249 phosphorylation (pp130Cas) levels are minimal in comparison to WT or
PEA3(−/−)-reconstituted cells. There were no major changes in c-src level or c-src
Tyr527 phosphorylation level (not shown). PL = poly-L-lysine, S = suspension.defects in these cells [7–9]. Here, we have shown that PEA3(−/−)
cells fail to efﬁciently undergo wound closure and migrate up to
4-times less than WT cells or PEA3(−/−)-reconstituted cells in
haptotaxis migration assays. Immunostaining of PEA3(−/−) cells
grown on FN revealed a reduced number of focal adhesions but nor-
mal distribution of focal adhesion complexes, as visualized by FAK,
paxillin and vinculin stains, suggesting that focal adhesion formation
or assembly is impaired. Interestingly, a reduced density of actin stress
ﬁbers was observed in PEA3-null cells. It is likely that the reduced
number of focal adhesions and aberrant focal adhesion signaling in
these cells results in altered actin dynamics. We have also observed
that PEA3(−/−) cells exhibit focal adhesion signaling defects charac-
terized mainly by the failure to efﬁciently activate c-src, resulting in
reduced p130Cas tyrosine phosphorylation and prolonged association
with FAK. It is likely that low c-src activity contributes to the reduced
levels of p130Cas phosphorylation at tyrosine 249 [35]. Furthermore,
we showed that the impairment in focal adhesion signaling is not
due to deregulation in c-src associationwith FAK or paxillin but rather
c-src kinase activity.
C-src activation is accomplished in several ways including post-
translational modiﬁcation andmolecular interactions [36]. Our results
show that FAK and paxillin interactions with c-src are not altered in
PEA3(−/−) cells, suggesting that c-src activation through such inter-
actions does not contribute to the observed inactivation of c-src in
PEA3(−/−) cells. One possibility is that kinases or phosphatases
that directly or indirectly activate c-src are encoded by PEA3 target
genes. In this study, only a subset of focal adhesion components was
surveyed for cellular distribution. Therefore, there is still a possibility
that the c-src-dependent recruitment of other adhesion proteins is
impaired.
Several studies have shown that focal adhesion turnover is a
microtubule-dependent process [37–40]. Microtubule depletion re-
sults in enlarged focal adhesions with high levels of FAK-pY397. In
addition, microtubule regrowth induces cycles of FAK dephosphoryla-
tion and rephosphorylation on tyrosine 397, suggesting that this is as-
sociated with turnover [37]. Interestingly, both c-src and v-src were
shown to be implicated inmicrotubule reorganization [41–43]. There-
fore, one possibility is that PEA3-null cells do not efﬁciently recruit the
microtubule network resulting in delayed focal adhesion turnover.
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this possibility.
Overall, our data suggest that the absence of pea3 gene expression
does not alter the levels of a subset of adhesionmarkers, including FAK
and the RhoGTPases. Interestingly, pea3 gene ablation may result in
the downregulation of c-src regulators, leading to a decrease in
FAK-src signaling, reduced levels of actin ﬁbers and an overall reduced
migration.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.09.002.
List of abbreviations
FAK focal adhesion kinase
FN ﬁbronectin
Y tyrosine
Cas Crk-associated substrate
MMTV mouse mammary tumor virus
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